Isolation of Anti-Inflammatory and Epithelium Reinforcing Bacteroides and Parabacteroides Spp. from A Healthy Fecal Donor
Year: 2020
Type: article
Abstract: Altered intestinal microbiota is associated with systemic and intestinal diseases, such as inflammatory bowel disease (IBD). Dysbiotic microbiota with enhanced proinflammatory capacity is characterized by depletion of anaerobic commensals, increased proportion of facultatively anaerobic bacteria, as well as reduced diversity and stability. In this study, we developed a high-throughput in vitro screening assay to isolate intestinal commensal bacteria with anti-inflammatory capacity from a healthy fecal microbiota transplantation donor. Freshly isolated gut bacteria were screened for their capacity to attenuate Escherichia coli lipopolysaccharide (LPS)-induced interleukin 8 (IL-8) release from HT-29 cells. The screen yielded a number of Bacteroides and Parabacteroides isolates, which were identified as P. distasonis, B. caccae, B. intestinalis, B. uniformis, B. fragilis, B. vulgatus and B. ovatus using whole genome sequencing. We observed that a cell-cell contact with the epithelium was not necessary to alleviate in vitro inflammation as spent culture media from the isolates were also effective and the anti-inflammatory action did not correlate with the enterocyte adherence capacity of the isolates. The anti-inflammatory isolates also exerted enterocyte monolayer reinforcing action and lacked essential genes to synthetize hexa-acylated, proinflammatory lipid A, part of LPS. Yet, the anti-inflammatory effector molecules remain to be identified. The Bacteroides strains isolated and characterized in this study have potential to be used as so-called next-generation probiotics.
Source: Nutrients
DOI: 10.3390/nu12040935
Authors: Kaisa Hiippala(Conceptualization, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing), Veera Kainulainen(Conceptualization, Funding acquisition, Methodology, Supervision, Validation, Writing – review & editing), Maiju Suutarinen(Validation, Writing – review & editing), Tuomas Heini(Validation, Writing – review & editing), Jolene R. Bowers(Formal analysis, Methodology, Validation, Writing – review & editing), Daniel Jasso-Selles(Formal analysis, Methodology, Visualization, Writing – review & editing), Darrin Lemmer(Formal analysis, Methodology, Writing – review & editing), Michael Valentine(Validation, Writing – review & editing), Riley Barnes(Validation, Writing – review & editing), David M. Engelthaler(Supervision, Writing – review & editing), Reetta Satokari(Conceptualization, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: Bacteroides, Parabacteroides, intestinal commensal bacteria, fecal microbiota transplantation, interleukin-8, lipopolysaccharide, HT-29 cells, epithelial barrier function, lipid A biosynthesis, Bacteroides fragilis, Bacteroides caccae, Bacteroides intestinalis, Bacteroides vulgatus, Bacteroides ovatus, Bacteroides uniformis, Parabacteroides distasonis, inflammatory bowel disease, probiotics, high-throughput assay
Open Access status: gold
Estimated APC paid: $2,112
Awards: G3935646020, G6150898234, G8408453562
OpenAlex ID: W3013957578
